0001070081-23-000033.txt : 20230606 0001070081-23-000033.hdr.sgml : 20230606 20230606160430 ACCESSION NUMBER: 0001070081-23-000033 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230606 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230606 DATE AS OF CHANGE: 20230606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 23996074 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 8-K 1 tmb-20230606x8k.htm 8-K
0001070081false00010700812023-06-062023-06-06

​

​

UNITED STATES

​

SECURITIES AND EXCHANGE COMMISSION

​

WASHINGTON, D.C. 20549

​

FORM 8-K

​

CURRENT REPORT

​

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported): June 6, 2023

​

PTC THERAPEUTICS, INC.

​

(Exact Name of Company as Specified in Charter)

​

​

​

​

​

​

Delaware

    

001-35969

    

04-3416587

(State or Other Jurisdiction

​

(Commission

​

(IRS Employer

of Incorporation)

​

File Number)

​

Identification No.)

​

​

​

​

​

100 Corporate Court

    

​

South Plainfield, NJ

​

07080

(Address of Principal Executive Offices)

​

(Zip Code)

​

Registrant’s telephone number, including area code: (908) 222-7000

​

Not applicable

​

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

​

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

​

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

​

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

​

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

​

​

​

​

​

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock, $0.001 par value per share

​

PTCT

​

Nasdaq Global Select Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

​

​

​

​

Item 5.07. Submission of Matters to a Vote of Security Holders.

​

PTC Therapeutics, Inc. (the “Company”) held its Annual Meeting on June 6, 2023 (the “Annual Meeting”). The final results for the votes regarding each proposal at the Annual Meeting are set forth below. As of the record date of the Annual Meeting, April 13, 2023, there were 74,026,696 shares of the Company’s common stock outstanding. Each share of common stock entitled its holder to one vote per share.

​

The stockholders of the Company elected four Class I directors, each to hold office until the Company’s 2026 annual meeting of stockholders or until his or her successor has been duly elected and qualified, as follows:

​

​

​

​

​

Director

For

Withheld

Broker Non-Votes

William F. Bell, Jr.

63,215,577

3,588,990

2,986,852

Matthew B. Klein, M.D., M.S., F.A.C.S.

66,478,887

325,680

2,986,852

Stephanie S. Okey, M.S.

63,816,731

2,987,836

2,986,852

Jerome B. Zeldis, M.D., Ph.D.

58,377,983

8,426,584

2,986,852

​

​

The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified by the Company’s stockholders with 69,370,823 votes “For,” 406,974 votes “Against,” and 13,622 votes “Abstained.”

​

The non-binding advisory proposal on named executive officer compensation was approved by the Company’s stockholders with 65,318,123 votes “For,” 1,464,756 votes “Against,” 21,688 votes “Abstained,” and 2,986,852 broker non-votes.

​

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

​

​

​

Exhibit No.

    

Description

104

​

The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

​

​

​

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​

​

​

PTC Therapeutics, Inc.

​

​

Date: June 6, 2023

By:

/s/ Mark E. Boulding

​

Name:

Mark E. Boulding

​

Title:

Executive Vice President and Chief Legal Officer

​

​

​

​

 EX-101.SCH 2 tmb-20230606.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 tmb-20230606_lab.xml EX-101.LAB EX-101.PRE 4 tmb-20230606_pre.xml EX-101.PRE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
Jun. 06, 2023
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Jun. 06, 2023
Entity File Number 001-35969
Entity Registrant Name PTC THERAPEUTICS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 04-3416587
Entity Address, Address Line One 100 Corporate Court
Entity Address, City or Town South Plainfield
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07080
City Area Code 908
Local Phone Number 222-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol PTCT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001070081
Amendment Flag false
XML 6 tmb-20230606x8k_htm.xml IDEA: XBRL DOCUMENT 0001070081 2023-06-06 2023-06-06 0001070081 false 8-K 2023-06-06 PTC THERAPEUTICS, INC. DE 001-35969 04-3416587 100 Corporate Court South Plainfield NJ 07080 908 222-7000 false false false false Common Stock, $0.001 par value per share PTCT NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports tmb-20230606x8k.htm tmb-20230606.xsd tmb-20230606_lab.xml tmb-20230606_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tmb-20230606x8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "tmb-20230606x8k.htm" ] }, "labelLink": { "local": [ "tmb-20230606_lab.xml" ] }, "presentationLink": { "local": [ "tmb-20230606_pre.xml" ] }, "schema": { "local": [ "tmb-20230606.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ptct", "nsuri": "http://www.ptcbio.com/20230606", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tmb-20230606x8k.htm", "contextRef": "Duration_6_6_2023_To_6_6_2023_RjK6cHJWVE-yRTvMxo_uJg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tmb-20230606x8k.htm", "contextRef": "Duration_6_6_2023_To_6_6_2023_RjK6cHJWVE-yRTvMxo_uJg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0001070081-23-000033-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001070081-23-000033-xbrl.zip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